Investment Summary |
|
|---|---|
| Date | 2019-01-24 |
| Target | Curative Cannabis |
| Sector | Business Services |
| Investor(s) | Auxly |
| Deal Type | Stake Purchase |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1987 |
| Sector | Business Services |
| Employees | 388 |
| Revenue | 122M USD (2024) |
Auxly is a vertically integrated cannabis company with diverse international operations. Auxly was founded in 1987 and is headquartered in Toronto, Ontario.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Business Services M&A | 1 of 1 |
| Type: Stake Purchase M&A Deals | 1 of 1 |
| State: Ontario M&A | 1 of 1 |
| Country: Canada M&A | 1 of 1 |
| Year: 2019 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-05-27 |
KGK Science
London, Ontario, Canada Founded in 1997, KGK Science is a contract research organization based in London, Ontario that primarily provides high-quality clinical research trials with a focus on the nutraceutical, cannabis, and emerging psychedelic industries. For over 23 years, the business has successfully helped hundreds of companies with custom-designed clinical trials and claim substantiation strategies to move products into global markets. KGK’s other existing service lines include expert regulatory support and compliance solutions, participant recruitment, research support services, and consulting services. On an approximate basis, the business to date has produced 150 publications, executed over 400 clinical trials across more than 40 indications, amassed 25,000 participants in its database, and collected 10 million data points. |
Sell | $17M |
